Mylan CEO Bresch Elected Chair Of GPhA
This article was originally published in Scrip
Mylan's CEO Heather Bresch has been elected chair of the Generic Pharmaceutical Association's (GPhA) board of directors. GPhA is an association that represents generic drug manufacturers and suppliers and Bresch's term as its board's chair will last for one year. Previously she served two one-year terms as chair of GphA in 2004 and 2005 and two one year terms as vice chair in 2003 and 2006.